MYC and metastatic neoplasm: In distant metastatic tumors, c-MYC protein overexpression, mRNA overexpression, and nuclear ß-catenin expression was detected in 37.3 % (66 out of 176), 74.6 % (132 out of 176) and 47.5 % (84 out of 176) of tumors, respectively.